Stem cell therapy in liver regeneration: Focus on mesenchymal stem cells and induced pluripotent stem cells
L Zhang, YY Fei, HT Han, J Xu, L Cheng, X Li - Pharmacology & …, 2022 - Elsevier
The liver has the ability to repair itself after injury; however, a variety of pathological changes
in the liver can affect its ability to regenerate, and this could lead to liver failure …
in the liver can affect its ability to regenerate, and this could lead to liver failure …
Hypoxia-conditioned mesenchymal stem cells in tissue regeneration application
Mesenchymal stem cells (MSCs) have been demonstrated as promising cell sources for
tissue regeneration due to their capability of self-regeneration, differentiation, and …
tissue regeneration due to their capability of self-regeneration, differentiation, and …
Mesenchymal stem cells as a cornerstone in a galaxy of intercellular signals: basis for a new era of medicine
S Fernández-Francos, N Eiro, LA Costa… - International journal of …, 2021 - mdpi.com
Around 40% of the population will suffer at some point in their life a disease involving tissue
loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with …
loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with …
Aging and mesenchymal stem cells: basic concepts, challenges and strategies
M Fraile, N Eiro, LA Costa, A Martín, FJ Vizoso - Biology, 2022 - mdpi.com
Simple Summary Aging and frailty are complex processes implicating multifactorial
mechanisms, which demand for new therapeutic strategies against their devastating effects …
mechanisms, which demand for new therapeutic strategies against their devastating effects …
Mesenchymal (Stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and …
N Eiro, M Fraile, A González-Jubete… - International journal of …, 2022 - mdpi.com
Inflammatory bowel diseases (IBD) are an example of chronic diseases affecting 40% of the
population, which involved tissue damage and an inflammatory process not satisfactorily …
population, which involved tissue damage and an inflammatory process not satisfactorily …
[HTML][HTML] Translational insights into stem cell preconditioning: from molecular mechanisms to preclinical applications
K Moeinabadi-Bidgoli, A Babajani… - Biomedicine & …, 2021 - Elsevier
Cell-based therapy (CBT) is a revolutionary approach for curing a variety of degenerative
diseases. Stem cell-based regenerative medicine is a novel strategy for treating tissue …
diseases. Stem cell-based regenerative medicine is a novel strategy for treating tissue …
Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies
MS Kahrizi, E Mousavi, A Khosravi, S Rahnama… - Stem cell research & …, 2023 - Springer
Mesenchymal stem/stromal cells (MSCs)‐based therapy brings the reassuring capability to
regenerative medicine through their self‐renewal and multilineage potency. Also, they …
regenerative medicine through their self‐renewal and multilineage potency. Also, they …
Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions
CL Braga, LR da Silva, RT Santos, LRP de Carvalho… - Cytotherapy, 2022 - Elsevier
Background aims Although bone marrow-derived mesenchymal stromal cells (MSCs) have
demonstrated success in pre-clinical studies, they have shown only mild therapeutic effects …
demonstrated success in pre-clinical studies, they have shown only mild therapeutic effects …
Nobiletin in cancer therapy: How this plant derived-natural compound targets various oncogene and onco-suppressor pathways
M Ashrafizadeh, A Zarrabi, S Saberifar, F Hashemi… - Biomedicines, 2020 - mdpi.com
Cancer therapy is a growing field, and annually, a high number of research is performed to
develop novel antitumor drugs. Attempts to find new antitumor drugs continue, since cancer …
develop novel antitumor drugs. Attempts to find new antitumor drugs continue, since cancer …
Mesenchymal stem cell therapy in kidney diseases: potential and challenges
F Chen, NN Chen, C Xia, H Wang, L Shao… - Cell …, 2023 - journals.sagepub.com
Kidney disease (KD) is a life-threatening disease characterized by high morbidity and
mortality in clinical settings, which can be caused by many reasons, and the incidence …
mortality in clinical settings, which can be caused by many reasons, and the incidence …